Cited by 131Antifungal resistance and susceptibilityFungal and yeast genetics researchFungal Plant Pathogen Control

The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.

Candida tropicalis Antifungal Cross-Resistance Is Related to Different Azole Target (Erg11p) Modifications

Open access

Forastiero, A., Mesa-Arango, A. C., Alastruey-Izquierdo, A., Alcazar-Fuoli, L., Bernal-Martinez, L., Pelaez, T., Lopez, J. F., Grimalt, J. O., Gomez-Lopez, A., Cuesta, I., Zaragoza, O., Mellado, E.·2013·Antimicrobial Agents and Chemotherapy

DOI 10.1128/aac.00477-13PMC PMC3811422

Open this paper in CoChat — free account Open PDF

Abstract

Candida tropicalis ranks between third and fourth among Candida species most commonly isolated from clinical specimens. Invasive candidiasis and candidemia are treated with amphotericin B or echinocandins as first-line therapy, with extended-spectrum triazoles as acceptable alternatives. Candida tropicalis is usually susceptible to all antifungal agents, although several azole drug-resistant clinical isolates are being reported. However, C. tropicalis resistant to amphotericin B is uncommon, and only a few strains have reliably demonstrated a high level of resistance to this agent. The resistance mechanisms operating in C. tropicalis strains isolated from clinical samples showing resistance to azole drugs alone or with amphotericin B cross-resistance were elucidated. Antifungal drug resistance was related to mutations of the azole target (Erg11p) with or without alterations of the ergosterol biosynthesis pathway. The antifungal drug resistance shown in vitro correlated very well with the results obtained in vivo using the model host Galleria mellonella. Using this panel of strains, the G. mellonella model system was validated as a simple, nonmammalian minihost model that can be used to study in vitro-in vivo correlation of antifungals in C. tropicalis. The development in C. tropicalis of antifungal drug resistance with different mechanisms during antifungal treatment has potential clinical impact and deserves specific prospective studies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1128/aac.00477-13

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling
Arnold, K., Bordoli, L., Kopp, J., & Schwede, T. F. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti770 · Cited by 7,031
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Multiple sequence alignment with Clustal X
Jeanmougin, F., Thompson, J. D., Gouy, M., Higgins, D. G., & Gibson, T. J. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01285-7 · Cited by 2,652
The SWISS-MODEL Repository and associated resources
Kiefer, F., Arnold, K., Künzli, M., Bordoli, L., & Schwede, T. F. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn750 · Cited by 2,003
Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment
Pfaller, M. A. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.11.001 · Cited by 903
Protein Modeling by E-mail
Peitsch, M. C. (1995) · Nature Biotechnology · doi:10.1038/nbt0795-658 · Cited by 814
Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences
Sanglard, D., & Odds, F. C. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00181-0 · Cited by 784
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion
Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Ellis, D., Tullio, V., Rodloff, A., Fu, W., & Ling, T. A. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02117-09 · Cited by 718
Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
Parczewska, O. K., Posaconazol, przeciwgrzybicze, L., Anidulafungina, Micafungina, & wrażliwość, O. (2009) · Cited by 656
Crystal structure of cytochrome P450 14α-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors
Podust, L. M., Poulos, T. L., & Waterman, M. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061562898 · Cited by 542

Flagged first, then by citations

Show all 78 references

Sorted by citations

Drug resistance and treatment failure in leishmaniasis: A 21st century challenge
Ponte‐Sucre, A., Gamarro, F., Dujardin, J., Barrett, M. P., López‐Vélez, R., García‐Hernández, R., Pountain, A. W., Mwenechanya, R., & Papadopoulou, B. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006052 · Cited by 971
An Update on Candida tropicalis Based on Basic and Clinical Approaches
Zuza-Alves, D. L., Rocha, W. P. D. S., & Chaves, G. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01927 · Cited by 314
The Production of Reactive Oxygen Species Is a Universal Action Mechanism of Amphotericin B against Pathogenic Yeasts and Contributes to the Fungicidal Effect of This Drug
Mesa-Arango, A. C., Trevijano-Contador, N., Román, E., Sánchez-Fresneda, R., Casas, C., Herrero, E., Argüelles, J. C., Pla, J., Cuenca-Estrella, M., & Zaragoza, O. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03570-14 · Cited by 232
Self-citation
Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens
Ksiezopolska, E., & Gabaldón, T. (2018) · Genes · doi:10.3390/genes9090461 · Cited by 230
Fungal Cell Wall: Emerging Antifungals and Drug Resistance.
Lima, S. L., Colombo, A. L., & de Almeida Junior, J. N. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02573 · Cited by 223
“…AMB resistance has been linked to several potential mechanisms, such as increase in catalase activity, changes in mitochondrial potential, low accumulation of reactive oxygen species, and deficiency in ergosterol at the cell membrane (Forastiero et al., 2013; Mesa-Arango et al., 2014).”
Background
SUSCEPTIBILITY TEST FOR FUNGI: CLINICAL AND LABORATORIAL CORRELATIONS IN MEDICAL MYCOLOGY
Alastruey‐Izquierdo, A., Melhem, M. D. S. C., Bonfietti, L. X., & Rodriguez-Tudela, J. L. (2015) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46652015000700011 · Cited by 184
Self-citation
Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus
Gonçalves, S. S., Souza, A. C. R., Chowdhary, A., Meis, J. F. G. M., & Colombo, A. L. (2016) · Mycoses · doi:10.1111/myc.12469 · Cited by 186
New pathogens, new tricks: emerging, drug‐resistant fungal pathogens and future prospects for antifungal therapeutics
Geddes‐McAlister, J., & Shapiro, R. S. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13739 · Cited by 162
The Quiet and Underappreciated Rise of Drug-Resistant Invasive Fungal Pathogens
Arastehfar, A., Lass-Flörl, C., Garcia-Rubio, R., Daneshnia, F., Ilkit, M., Boekhout, T., Gabaldon, T., & Perlin, D. S. (2020) · Journal of Fungi · doi:10.3390/jof6030138 · Cited by 145
Fungal Lanosterol 14α-demethylase: A target for next-generation antifungal design
Monk, B. C., Sagatova, A. A., Hosseini, P., Ruma, Y. N., Wilson, R. K., & Keniya, M. V. (2019) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2019.02.008 · Cited by 148
Candida glabrata Biofilms: How Far Have We Come?
Rodrigues, C., Rodrigues, M., Silva, S., & Henriques, M. (2017) · Journal of Fungi · doi:10.3390/jof3010011 · Cited by 129
Candida parapsilosis Resistance to Fluconazole: Molecular Mechanisms and In Vivo Impact in Infected Galleria mellonella Larvae
Souza, A. C. R., Fuchs, B. B., Pinhati, H. M. S., Siqueira, R. A., Hagen, F., Meis, J. F., Mylonakis, E., & Colombo, A. L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01177-15 · Cited by 121
Current status of antifungal resistance and its impact on clinical practice
Alcázar‐Fuoli, L., & Mellado, E. (2014) · British Journal of Haematology · doi:10.1111/bjh.12896 · Cited by 118
Self-citation
Molecular mechanisms of fluconazole resistance in Candida parapsilosis isolates from a U.S. surveillance system
Grossman, N. T., Pham, C. D., Cleveland, A. A., & Lockhart, S. R. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04613-14 · Cited by 112
Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole
Espinel-Ingroff, A., Pfaller, M. A., Bustamante, B., Canton, E., Fothergill, A., Fuller, J., Gonzalez, G. M., Lass-Flörl, C., Lockhart, S. R., Martin-Mazuelos, E., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02615-13 · Cited by 105
Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination
Castanheira, M., Deshpande, L. M., Messer, S. A., Rhomberg, P. R., & Pfaller, M. A. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.09.003 · Cited by 107
Antifungal Resistance, Metabolic Routes as Drug Targets, and New Antifungal Agents: An Overview about Endemic Dimorphic Fungi
Parente-Rocha, J. A., Bailão, A. M., Amaral, A. C., Taborda, C. P., Paccez, J. D., Borges, C. L., & Pereira, M. (2017) · Mediators of Inflammation · doi:10.1155/2017/9870679 · Cited by 93
Molecular mechanisms of azole resistance in Candida tropicalis isolates causing invasive candidiasis in China
Fan, X., Xiao, M., Zhang, D., Huang, J.-J., Wang, H., Hou, X., Zhang, L., Kong, F., Chen, S. C.-A., Tong, Z., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.11.007 · Cited by 99
Galleria mellonella for the Evaluation of Antifungal Efficacy against Medically Important Fungi, a Narrative Review
Jemel, S., Guillot, J., Kallel, K., Botterel, F., & Dannaoui, É. (2020) · Microorganisms · doi:10.3390/microorganisms8030390 · Cited by 94
Facilitators of adaptation and antifungal resistance mechanisms in clinically relevant fungi
Hokken, M., Zwaan, B. J., Melchers, W. J. G., & Verweij, P. E. (2019) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2019.103254 · Cited by 98
Drug resistance mechanisms and their regulation in non- albicans Candida species
Kołaczkowska, A., & Kołaczkowski, M. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv445 · Cited by 91
Cell Wall changes in amphotericin B-resistant strains from Candida tropicalis and relationship with the immune responses elicited by the host
Mesa-Arango, A. C., Rueda, C., Román, E., Quintin, J., Terrón, M. C., Luque, D., Netea, M. G., Pla, J., & Zaragoza, O. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02681-15 · Cited by 86
Self-citation
Antifungal drug resistance in Candida species
Morace, G., Perdoni, F., & Borghi, E. (2014) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2014.09.002 · Cited by 80
Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications
Rogers, T. R., Verweij, P. E., Castanheira, M., Dannaoui, E., White, P. L., Arendrup, M. C., Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST), Arendrup, M. C., Arikan-Akdagli, S., Barchiesi, F., et al. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac161 · Cited by 82
Sterol 14α-Demethylase Ligand-Binding Pocket-Mediated Acquired and Intrinsic Azole Resistance in Fungal Pathogens
Rosam, K., Monk, B. C., & Lackner, M. (2020) · Journal of Fungi · doi:10.3390/jof7010001 · Cited by 84
The emerging threat antifungal-resistant Candida tropicalis in humans, animals, and environment
Lima, R., Ribeiro, F. D. C., Colombo, A. L., & de Almeida, J. N. (2022) · Frontiers in Fungal Biology · doi:10.3389/ffunb.2022.957021 · Cited by 79
Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in Candida and Aspergillus Species for the Sensititre YeastOne Colorimetric Broth and Etest Agar Diffusion Methods
Espinel‐Ingroff, A., Turnidge, J. D., Alastruey‐Izquierdo, A., Botterel, F., Cantón, R., Castro, C., Chen, Y., Chen, Y., Chryssanthou, E., Dannaoui, É., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01651-18 · Cited by 75
Self-citation
Galleria mellonella: An invertebrate model to study pathogenicity in correctly defined fungal species
Binder, U., Maurer, E., & Lass‐Flörl, C. (2015) · Fungal Biology · doi:10.1016/j.funbio.2015.06.002 · Cited by 72
Fluconazole‐resistant Candida parapsilosis strains with a Y132F substitution in the ERG11 gene causing invasive infections in a neonatal unit, South Africa
Magobo, R. E., Lockhart, S. R., & Govender, N. P. (2020) · Mycoses · doi:10.1111/myc.13070 · Cited by 69
Resistance Mechanisms and Clinical Features of Fluconazole-Nonsusceptible Candida tropicalis Isolates Compared with Fluconazole-Less-Susceptible Isolates
Choi, M. J., Won, E. J., Shin, J. H., Kim, S. H., Lee, W. G., Kim, M., Lee, K., Shin, M., Suh, S., Ryang, D. W., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02652-15 · Cited by 72
A One Health approach to overcoming fungal disease and antifungal resistance
Woods, M., McAlister, J. A., & Geddes‐McAlister, J. (2023) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1610 · Cited by 72
Synergistic activity of magnolol with azoles and its possible antifungal mechanism against Candida albicans
Sun, L.-M., Liao, K., Liang, S., Yu, P.-H., & Wang, D.-Y. (2015) · Journal of Applied Microbiology · doi:10.1111/jam.12737 · Cited by 67
Understanding the mechanisms of resistance to azole antifungals in Candida species
Li, Y., Hind, C. K., Furner-Pardoe, J., Sutton, J. M., & Rahman, K. M. (2025) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaf106 · Cited by 70
Linking Cellular Morphogenesis with Antifungal Treatment and Susceptibility in Candida Pathogens
Sharma, J., Rosiana, S., Razzaq, I., & Shapiro, R. S. (2019) · Journal of Fungi · doi:10.3390/jof5010017 · Cited by 69
MDR1 overexpression combined with ERG11 mutations induce high-level fluconazole resistance in Candida tropicalis clinical isolates
Jin, L., Cao, Z., Wang, Q., Wang, Y., Wang, X., Chen, H., & Wang, H. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3082-0 · Cited by 55
The effect of antifungal resistance development on the virulence of Candida species
Bohner, F., Papp, C., & Gácser, A. (2022) · FEMS Yeast Research · doi:10.1093/femsyr/foac019 · Cited by 72
Antifungal drug resistance in Candida: a special emphasis on amphotericin B
Ahmady, L., Gothwal, M., Mukkoli, M. M., & Bari, V. K. (2024) · Apmis · doi:10.1111/apm.13389 · Cited by 61
An Overview on Conventional and Non-Conventional Therapeutic Approaches for the Treatment of Candidiasis and Underlying Resistance Mechanisms in Clinical Strains
Salazar, S. B., Simões, R., Pedro, N. A., Pinheiro, M. J. F., Carvalho, M. F. N. N., & Mira, N. P. (2020) · Journal of Fungi · doi:10.3390/jof6010023 · Cited by 58
Candida tropicalis bloodstream infection: Incidence, risk factors and outcome in a population-based surveillance
Fernández‐Ruiz, M., Puig‐Asensio, M., Guinea, J., Almirante, B., Padilla, B., Almela, M., Díaz‐Martín, A., Rodríguez‐Baño, J., Cuenca‐Estrella, M., & Aguado, J. M. (2015) · Journal of Infection · doi:10.1016/j.jinf.2015.05.009 · Cited by 54
Lipid core nanoparticles as a broad strategy to reverse fluconazole resistance in multiple Candida species
Bianchin, M. D., Borowicz, S. M., Machado, G. D. R. M., Pippi, B., Guterres, S. S., Pohlmann, A. R., Fuentefría, A. M., & Külkamp‐Guerreiro, I. C. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.12.011 · Cited by 52
Unmasking the Amphotericin B Resistance Mechanisms in Candida haemulonii Species Complex
Silva, L. N., Oliveira, S. S. C., Magalhães, L. B., Andrade-Neto, V. V., Torres-Santos, E. C., de Carvalho, M. D. C., Pereira, M. D., Branquinha, M. H., & dos Santos, A. L. S. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00117 · Cited by 50
Mechanisms of azole antifungal resistance in clinical isolates of Candida tropicalis
Paul, S., Shaw, D., Joshi, H. N., Singh, S., Chakrabarti, A., Rudramurthy, S. M., & Ghosh, A. K. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269721 · Cited by 47
Widespread amphotericin B-resistant strains of Aspergillus fumigatus in Hamilton, Canada
Ashu, E. E., Korfanty, G. A., Samarasinghe, H., Pum, N., You, M., Yamamura, D. L. R., & Xu, J. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s170952 · Cited by 49
A Cyp51B Mutation Contributes to Azole Resistance in Aspergillus fumigatus
González-Jiménez, I., Lucio, J., Amich, J., Cuesta, I., Arroyo, R. S., Alcázar‐Fuoli, L., & Mellado, E. (2020) · Journal of Fungi · doi:10.3390/jof6040315 · Cited by 50
Self-citation
Role of Antifungal Combinations in Difficult to Treat Candida Infections
Vitale, R. G. (2021) · Journal of Fungi · doi:10.3390/jof7090731 · Cited by 51
Implications of the EUCAST Trailing Phenomenon in Candida tropicalis for the In Vivo Susceptibility in Invertebrate and Murine Models
Astvad, K. M. T., Sanglard, D., Delarze, E., Hare, R. K., & Arendrup, M. C. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01624-18 · Cited by 43
Novel point mutations in the ERG11 gene in clinical isolates of azole resistant Candida species
Silva, D. B. D. S., Rodrigues, L. M. C., Almeida, A. A. D., Oliveira, K. M. P. D., & Grisolia/, A. B. (2016) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760150400 · Cited by 42
Antiproliferation of Berberine in Combination with Fluconazole from the Perspectives of Reactive Oxygen Species, Ergosterol and Drug Efflux in a Fluconazole-Resistant Candida tropicalis Isolate
Shao, J., Shi, G., Wang, T., Wu, D., & Wang, C. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01516 · Cited by 40
Blood and intra-abdominal Candida spp. from a multicentre study conducted in Madrid using EUCAST: emergence of fluconazole resistance in Candida parapsilosis, low echinocandin resistance and absence of Candida auris
Díaz-García, J., Gómez, A., Machado, M., Alcalá, L., Reigadas, E., Sánchez-Carrillo, C., Pérez-Ayala, A., Gómez-García De La Pedrosa, E., González-Romo, F., Cuétara, M. S., et al. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac288 · Cited by 35
The yeast, the antifungal, and the wardrobe: a journey into antifungal resistance mechanisms of Candida tropicalis
de Oliveira, J. S., Pereira, V. S., Castelo‐Branco, D. D. S. C. M., Cordeiro, R. D. A., Sidrim, J. J. C., Brilhante, R. S. N., & Rocha, M. F. G. (2020) · Canadian Journal of Microbiology · doi:10.1139/cjm-2019-0531 · Cited by 38
Mechanisms of Azole Resistance and Trailing in Candida tropicalis Bloodstream Isolates
Chen, P., Chuang, Y., Wu, U., Sun, H., Wang, J., Sheng, W., Chen, Y., & Chang, S. (2021) · Journal of Fungi · doi:10.3390/jof7080612 · Cited by 32
Synthesis, activity, and docking studies of eugenol‐based glucosides as new agents against Candida sp.
Hipólito, T. M. M., Bastos, G. T. L., Barbosa, T. W. L., de Souza, T. B., Coelho, L. F. L., Dias, A. L. T., Camps, I., dos Santos, M. H., Dias, D. F., Franco, L. L., et al. (2018) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13318 · Cited by 32
Dynamics of in vitro development of azole resistance in Candida tropicalis
Paul, S., Singh, S., Sharma, D., Chakrabarti, A., Rudramurthy, S. M., & Ghosh, A. K. (2020) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2020.04.018 · Cited by 33
Point Mutations in the 14-α Sterol Demethylase Cyp51A or Cyp51C Could Contribute to Azole Resistance in Aspergillus flavus
Lucio, J. L., González-Jiménez, I., Rivero-Menéndez, O., Alastruey‐Izquierdo, A., Peláez, T., Alcázar‐Fuoli, L., & Mellado, E. (2020) · Genes · doi:10.3390/genes11101217 · Cited by 33
Self-citation
Epidemiology of antifungal susceptibility: Review of literature
Hadrich, I., & Ayadi, M. A. (2018) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2018.04.011 · Cited by 30
Collateral sensitivity counteracts the evolution of antifungal drug resistance in Candida auris
Carolus, H., Sofras, D., Boccarella, G., Jacobs, S., Biriukov, V. V., Goossens, L., Chen, A., Vantyghem, I., Verbeeck, T., Pierson, S., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01811-w · Cited by 27
The role of metabolism in shaping enzyme structures over 400 million years
(2025) · doi:10.1038/s41586-025-09205-6 · Cited by 28
Anticandidal synergistic activity of Ocimum sanctum and fluconazole of azole resistance strains of clinical isolates
Zaidi, K. U., Shah, F., Parmar, R., & Thawani, V. (2018) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2018.04.004 · Cited by 26
Precise genome editing using a CRISPR-Cas9 method highlights the role of CoERG11 amino acid substitutions in azole resistance in Candida orthopsilosis
Morio, F., Lombardi, L., Binder, U., Logé, C., Robert, E., Grässle, D., Bodin, M., Lass‐Flörl, C., Butler, G., & Pape, P. L. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz204 · Cited by 29
Silver diamine fluoride (SDF) used in childhood caries management has potent antifungal activity against oral Candida species
Fakhruddin, K. S., Egusa, H., Ngo, H. C., Panduwawala, C., Pesee, S., Venkatachalam, T., & Samaranayake, L. P. (2020) · BMC Microbiology · doi:10.1186/s12866-020-01776-w · Cited by 25
Characterization of Virulence Factors in Candida Species Causing Candidemia in a Tertiary Care Hospital in Bangkok, Thailand
Saiprom, N., Wongsuk, T., Oonanant, W., Sukphopetch, P., Chantratita, N., & Boonsilp, S. (2023) · Journal of Fungi · doi:10.3390/jof9030353 · Cited by 28
Insights into the Multi-Azole Resistance Profile in Candida haemulonii Species Complex
Silva, L. N., Ramos, L. S., de Oliveira, S. S. C., Magalhães, L. B., Squizani, E. D., Kmetzsch, L., Vainstein, M. H., Branquinha, M. H., & dos Santos, A. L. S. (2020) · Journal of Fungi · doi:10.3390/jof6040215 · Cited by 27
Caspofungin and Polymyxin B Reduce the Cell Viability and Total Biomass of Mixed Biofilms of Carbapenem-Resistant Pseudomonas aeruginosa and Candida spp.
Fernandes, L., Fortes, B. N., Lincopán, N., & Ishida, K. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.573263 · Cited by 26
Does the use of antifungal agents in agriculture and food foster polyene resistance development? A reason for concern
Dalhoff, A. (2017) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2017.10.024 · Cited by 26
Azole Resistance and ERG11 Mutation in Clinical Isolates of Candida tropicalis
Siqueira, A. C., Bernardi, G., Arend, L. N. V. S., Cordeiro, G. T., Rosolen, D., Berti, F. C. B., Ferreira, A. M. M., Vasconcelos, T. M., Neves, B. C., Rodrigues, L. S., et al. (2025) · Journal of Fungi · doi:10.3390/jof11010024 · Cited by 22
Acquired multi-azole resistance in Candida tropicalis during persistent urinary tract infection in a dog
Álvarez‐Pérez, S., García, M. E., Cutuli, M. T., Fermín, M. L., Daza, M. Á., Peláez, T., & Blanco, J. L. (2016) · Medical Mycology Case Reports · doi:10.1016/j.mmcr.2016.02.001 · Cited by 22
Research progress on the drug resistance mechanisms of Candida tropicalis and future solutions
Xiong, H., Zhao, R., Han, S., Liu, Z., Zhang, X., Jia, Z., Cui, J., Zhang, Y., & Wang, X. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1594226 · Cited by 23
Antifungal treatment strategies and their impact on resistance development in clinical settings
van Rhijn, N., & White, P. L. (2025) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaf382 · Cited by 27
Transcription Factor ADS-4 Regulates Adaptive Responses and Resistance to Antifungal Azole Stress
Wang, K., Zhang, Z., Chen, X., Sun, X., Jin, C., Liu, H., & Li, S. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00542-15 · Cited by 21
Total Protein Profile and Drug Resistance inCandida albicansIsolated from Clinical Samples
Zaidi, K. U., Mani, A., Thawani, V., & Mehra, A. (2016) · Molecular Biology International · doi:10.1155/2016/4982131 · Cited by 21
Butyrolactol A enhances caspofungin efficacy via flippase inhibition in drug-resistant fungi
Chen, X., Duan, H. D., Hoy, M. J., Koteva, K. K., Spitzer, M., Guitor, A. K., Puumala, E., Fiebig‐Comyn, A., Hu, G., Yiu, B., et al. (2025) · Cell · doi:10.1016/j.cell.2025.11.036 · Cited by 23
Water Quality, Heavy Metals, and Antifungal Susceptibility to Fluconazole of Yeasts from Water Systems
Caicedo-Bejarano, L. D., Osorio-Vanegas, L. S., Ramírez-Castrillón, M., Castillo, J. E., Martínez-Garay, C. A., & Chávez, M. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20043428 · Cited by 19
In Vitro Activity of Essential Oils Distilled from Colombian Plants against Candidaauris and Other Candida Species with Different Antifungal Susceptibility Profiles
Zapata-Zapata, C., Loaiza-Oliva, M., Pabón, M. C. M., Stashenko, E. E., & Mesa-Arango, A. C. (2022) · Molecules · doi:10.3390/molecules27206837 · Cited by 18
Self-citation
Analysis of CDR1 and MDR1 Gene Expression and ERG11 Substitutions in Clinical Candida tropicalis Isolates from Alexandria, Egypt
El‐Kholy, M. A., Helaly, G. F., Ghazzawi, E. F. E., El-Sawaf, G., & Shawky, S. M. (2023) · Brazilian Journal of Microbiology · doi:10.1007/s42770-023-01106-y · Cited by 18
The Effects of Tormentic Acid and Extracts from Callistemon citrinus on Candida albicans and Candida tropicalis Growth and Inhibition of Ergosterol Biosynthesis in Candida albicans
Bvumbi, C. W., Fru, G., Stevens, M. Y., Mombeshora, M., & Mukanganyama, S. (2021) · The Scientific World JOURNAL · doi:10.1155/2021/8856147 · Cited by 19
Antifungal Activity of Plant Secondary Metabolites on Candida albicans: An Updated Review
Khan, A., Moni, S. S., Ali, M., Mohan, S., Jan, H., Rasool, S., Kamal, M. A., Alshahrani, S., Halawi, M., & Alhazmi, H. A. (2023) · Current Molecular Pharmacology · doi:10.2174/1874467215666220304143332 · Cited by 17
Commercial Methods for Antifungal Susceptibility Testing of Yeasts: Strengths and Limitations as Predictors of Resistance
Espinel‐Ingroff, A. (2022) · Journal of Fungi · doi:10.3390/jof8030309 · Cited by 19
A clinical analysis of Candida tropicalis bloodstream infections associated with hematological diseases, and antifungal susceptibility: a retrospective survey
Yang, B., Wei, Z., Wu, M., Lai, Y., & Zhao, W. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1092175 · Cited by 17
Etest ECVs/ECOFFs for Detection of Resistance in Prevalent and Three Nonprevalent Candida spp. to Triazoles and Amphotericin B and Aspergillus spp. to Caspofungin: Further Assessment of Modal Variability
Espinel‐Ingroff, A., Sasso, M., Turnidge, J. D., Arendrup, M. C., Botterel, F., Bourgeois, N., Bouteille, B., Cantón, R., Cassaing, S., Dannaoui, É., et al. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01093-21 · Cited by 17
Self-citation
Diversity of Toxigenic Molds and Mycotoxins Isolated from Dairy Products: Antifungal Activity of Egyptian Marine Algae on Aspergillus and Candida Species
Ahmed, A. E., Al-Kahtani, M. A., El-Diasty, E. M., Ahmed, A. S., Saber, H., Abbas, A., Diab, H. M., AlShehri, M. A., El‐Mansi, A. A., & Hussein, M. A. (2020) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.14.1.23 · Cited by 16
Novel Sulfones with Antifungal Properties: Antifungal Activities and Interactions with Candida spp. Virulence Factors
Gizińska, M., Staniszewska, M., & Ochal, Z. (2018) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557518666180924121209 · Cited by 15
Resistance rates of non-albicans Candida infections in Taiwan after the revision of 2012 Clinical and Laboratory Standards Institute breakpoints
Hii, I.-M., Liu, C.-E., Lee, Y.-L., Liu, W., Wu, P.-F., Hsieh, M.-H., Ho, M., Chen, Y., & Wang, F. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s184884 · Cited by 15
ClCPI, a cysteine protease inhibitor purified from Cassia leiandra seeds has antifungal activity against Candida tropicalis by inducing disruption of the cell surface
Melo, I. R. S., Dias, L. P., Araújo, N. M. S., Vasconcelos, I. M., Martins, T. F., de Morais, G. A., Gonçalves, J. F. D. C., Nagano, C. S., Carneiro, R. F., & Oliveira, J. T. A. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.04.174 · Cited by 15
Phytochemical profile and antimicrobial activity of Jatropha curcas extracts against oral microorganisms
Kamaruddin, A., Harun, W. H. F. W., Bakri, M., Abidin, S. A. Z., Giribabu, N., & Rahman, S. N. S. A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33422 · Cited by 9
Emerging Role of Sphingolipids in Amphotericin B Drug Resistance
Madaan, K., & Bari, V. K. (2023) · Microbial Drug Resistance · doi:10.1089/mdr.2022.0353 · Cited by 12
Genotyping and susceptibility testing uncovers large azole-resistant Candida tropicalis clade in Alexandria, Egypt
Spruijtenburg, B., Meijer, E. F. J., Xiao, M., Shawky, S. M., Meis, J. F. G. M., de Groot, T., & El‐Kholy, M. A. (2023) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2023.06.012 · Cited by 13
Molecular epidemiology and azole resistance mechanism study of Candida guilliermondii from a Chinese surveillance system
Cheng, J.-W., Liao, K., Kudinha, T., Yu, S.-Y., Xiao, M., Wang, H., Kong, F., & Xu, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-01106-7 · Cited by 13
The Risk Factors and Mechanisms of Azole Resistance of Candida tropicalis Blood Isolates in Thailand: A Retrospective Cohort Study
Leepattarakit, T., Tulyaprawat, O., & Ngamskulrungroj, P. (2022) · Journal of Fungi · doi:10.3390/jof8100983 · Cited by 8
Expanding the therapeutic options for Candida infections using novel inhibitors of secreted aspartyl proteases
Chakraborty, S., Rahate, K., Kumar, C., & Idicula‐Thomas, S. (2022) · Drug Development Research · doi:10.1002/ddr.22015 · Cited by 8
Lippia origanoides Essential Oil or Thymol in Combination with Fluconazole Produces Damage to Cells and Reverses the Azole-Resistant Phenotype of a Candida tropicalis Strain
Zapata-Zapata, C., Rojas, M., García, L. T., Quintero, W., Terrón, M. C., Luque, D., & Mesa-Arango, A. C. (2023) · Journal of Fungi · doi:10.3390/jof9090888 · Cited by 9
Self-citation
Alternative Oxidase – Aid or obstacle to combat the rise of fungal pathogens?
Edrich, E. S. M., Duvenage, L., & Gourlay, C. W. (2024) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2024.149031 · Cited by 7
Ketoconazole/calix[n]arenes-based compounds improve the antifungal activity against azole-resistant Candida isolates
Spadari, C. D. C., Barreto, T. L., de Queiroz, V. T., de Paiva, W. F., Fernandes, S. A., de Fátima, Â., & Ishida, K. (2022) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2022.101254 · Cited by 5
Azole Antifungal Drugs: Mode of Action and Resistance
Garcia‐Rubio, R., Monteiro, M. C., & Mellado, E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.20731-0 · Cited by 9
Self-citation
Phenotypic Impact and Multivariable Assessment of Antifungal Susceptibility in Candida auris Survival Using a Galleria mellonella Model
Alvarruiz, J., Gaitán, A. C. R., Cabañero-Navalón, M. D., Pemán, J., Blanes-Hernández, R., Tejido, S. D. C., & García-Bustos, V. (2025) · Journal of Fungi · doi:10.3390/jof11060406 · Cited by 5
A MALDI-TOF MS-based multiple detection panel of drug resistance-associated multiple single-nucleotide polymorphisms in Candida tropicalis
Wan, F., Zhang, M., Guo, J., Lin, H., Zhou, X., Wang, L., & Wu, W. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.00764-24 · Cited by 6
Nephrotoxicity and fungal resistance associated with Amphotericin B
Berto, C., & Dalzochio, T. (2021) · Saúde e meio ambiente revista interdisciplinar · doi:10.24302/sma.v10.2720 · Cited by 6
Candida bloodstream infection: A clinical microbiology laboratory perspective
Pongrácz, J., & Kristóf, K. (2014) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/amicr.61.2014.3.11 · Cited by 4
Traditional Medicinal Plants of Higher Altitude of Himachal Pradesh as Functional Food Ingredient Cum Food Preservative and Bioavailability Enhancer of Anifungal AntibioticsPreprint
Rolta, R., Sharma, A., Kumar, V., Chauhan, P. K., Sourirajan, A., & Dev, K. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3299285 · Cited by 5
Candidemia chronicles: Retrospective analysis of candidemia epidemiology, species distribution, and antifungal susceptibility patterns in Bahrain
Saeed, N. K., Almusawi, S., & Al‐Beltagi, M. (2024) · World Journal of Virology · doi:10.5501/wjv.v13.i4.98839 · Cited by 4
Mycological Profile of Candida tropicalis and its Virulence Factors from Candidemia Patients at A Tertiary Care Facility
Mohanraj, H., Vinodhini, V. M., & Vajravelu, L. K. (2023) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.17.2.27 · Cited by 7

Authors: Forastiero, A., Mesa-Arango, A. C., Alastruey-Izquierdo, A., Alcazar-Fuoli, L., Bernal-Martinez, L., Pelaez, T., Lopez, J. F., Grimalt, J. O., Gomez-Lopez, A., Cuesta, I., Zaragoza, O., & Mellado, E.
Affiliations: Instituto de Salud Carlos III (ES)
Mycology Reference Laboratory, Centro Nacional de Microbiologia, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, and Department of Medicine, Faculty of Medicine, Universidad Complutense, Madrid, Spain
Departamento de Química Ambiental, Institute of Environmental Assessment and Water Research (IDÆA), Consejo Superior de Investigaciones Científicas, Barcelona, Spain
Consejo Superior de Investigaciones Científicas (ES)
ORCID: Forastiero, A.
Mesa-Arango, A. C.
Grimalt, J. O.
Cuesta, I.
Mellado, E.
Venue: Antimicrobial Agents and Chemotherapy
Publisher: American Society for Microbiology
Published: 2013-10
Volume: 57
Issue: 10
Pages: 4769-4781
ISSN: 0066-4804 (ISSN-L)
1098-6596
DOI: 10.1128/aac.00477-13
PMC: PMC3811422
OpenAlex: W2115223992
Cited by: 131
References: 78
Citations by year: 2026: 3 · 2025: 14 · 2024: 7 · 2023: 15 · 2022: 13 · 2021: 7 · 2020: 14 · 2019: 10 · 2018: 15 · 2017: 6 · 2016: 9 · 2015: 7 · 2014: 9 · 2013: 1
FWCI: 6.30
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Antimicrobial Agents and Chemotherapy (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Institutional Repository University of Antioquia (University of Antioquia) (submittedVersion, cc-by)
Topics: Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
Keywords: Candida tropicalis, antifungal resistance, azole resistance, cross-resistance, amphotericin B resistance, ergosterol biosynthesis, Galleria mellonella, in vitro-in vivo correlation, invasive candidiasis, candidemia, echinocandins, triazoles
MeSH terms: Amphotericin B, Antifungal Agents, Azoles, Fungal Proteins, Drug Resistance, Fungal, Candida tropicalis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Candida tropicalis Antifungal Cross-Resistance Is Related to Different Azole Target (Erg11p) Modifications

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks